Search NEO
NeoGenomics, Inc.
NasdaqCM · CIK 1077183
Last close18.47
Daily change+0.69 (3.88%)
10 Years gain+128.87%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NEO · STANDARD
SIC 8734 · Services-Testing Laboratories · Fiscal year end 1231
Fundamental
50.3Momentum
n/aAcceleration
n/aConfidence
63.0Annual Revenue8
Quarterly Revenue39
Annual CFO13
Balance SheetMissing
RankingLimited
Score Breakdown
Growth18.7 / 25
Quality14.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Key Metrics
Revenue Growth TTM8.75%OK
Revenue CAGR 3Y272.59%OK
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | n/a | $314.29M | -$115.88M | $5.23M | -$21.78M | n/a | n/a | n/a | -8.74% | 128.1M |
| 2025 FY Dec 31, 2024 | n/a | $290.10M | -$92.11M | $7.02M | -$34.04M | n/a | n/a | n/a | -6.57% | 126.66M |
| 2025 FY Dec 31, 2023 | n/a | $244.60M | -$107.74M | -$1.95M | -$30.71M | n/a | n/a | n/a | -9.09% | 125.5M |
| 2024 FY Dec 31, 2022 | n/a | $187.90M | -$157.62M | -$65.99M | -$96.88M | n/a | n/a | n/a | -18.76% | 124.22M |
| 2023 FY Dec 31, 2021 | n/a | $187.06M | -$118.75M | -$26.72M | -$90.87M | n/a | n/a | n/a | -18.94% | 119.96M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $262.01M | sum latest 4 fiscal quarters Revenue | OK | 0001564590-18-005479, 0001077183-18-000017 |
| Revenue Growth TTM | 8.75% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001564590-18-005479, 0001077183-18-000017 |
| Revenue CAGR 3Y | 272.59% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001564590-18-005479 |
| Revenue CAGR 5Y | 120.16% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001564590-18-005479 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 1.74x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | derived |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | derived |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |
| Gross Margin Delta 3Y | n/a | GrossMargin_current - GrossMargin_3Y_ago | INSUFFICIENT_HISTORY | derived |